Tumour cell-antibody interactions. I. In vivo experiments

Area of Science:

• Immunology
• Oncology
• Biochemistry

Background:

• Development of targeted immunotherapies for cancer relies on effective antibody delivery to tumor sites.
• The L5178Y murine tumor model provides a platform for studying antibody-tumor interactions.

Purpose of the Study:

• To investigate the in vivo behavior and tumor-specific accumulation of goat anti-L5178Y tumor IgG fractions.
• To determine the factors influencing antibody localization and retention within tumor tissues.

Main Methods:

• Goats were immunized with L5178Y tumor membrane fractions.
• Antiserum IgG was purified and rendered tumor-specific through in vitro and in vivo absorption techniques.
• 125I-labeled antibodies were administered to mice bearing L5178Y tumors to assess in vivo distribution and clearance.

Main Results:

• Extensive purification and concentration of tumor-specific antibodies did not enhance their accumulation in tumor tissue.
• Radioactivity clearance rates from tumors and whole animals were accelerated in the presence of target cells.
• Antibody metabolism was significantly increased when antibodies interacted with target tumor cells.

Conclusions:

• Rapid neutralization and degradation of antibodies by target tumor tissue impede their accumulation in tumor nodules.
• These findings suggest that the tumor microenvironment actively degrades antibodies, limiting their therapeutic potential.
• Strategies to overcome rapid antibody clearance may be necessary for effective antibody-based cancer therapies.